XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total Share holders’ Equity
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accum. Other Comp- rehensive Income (loss), net
Non- Controlling Interests
Beginning balance (in shares) at Dec. 31, 2023     18,968,448        
Beginning balance at Dec. 31, 2023 $ 447,976 $ 414,520 $ 1,897 $ 66,706 $ 345,882 $ 35 $ 33,456
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock option grant compensation 58 58   58      
Restricted stock compensation 955 955   955      
Shares granted to Directors (in shares)     19,356        
Shares granted to Directors 600 600 $ 2 598      
Restricted stock award (shares)     42,670        
Restricted stock award 0 0 $ 4 (4)      
Net income (loss) 4,773 4,706     4,706   67
Contributions from partner 15,102           15,102
Distributions to partners (2,406)           (2,406)
Minimum pension liability,net (23) (23)       (23)  
Unrealized gains on investment, net 68 68       68  
Ending balance (in shares) at Sep. 30, 2024     19,030,474        
Ending balance at Sep. 30, 2024 467,103 420,884 $ 1,903 68,313 350,588 80 46,219
Beginning balance (in shares) at Jun. 30, 2024     19,030,474        
Beginning balance at Jun. 30, 2024 451,148 419,132 $ 1,903 67,980 349,227 22 32,016
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock option grant compensation 19 19   19      
Restricted stock compensation 314 314   314      
Net income (loss) 1,379 1,361     1,361   18
Contributions from partner 15,102           15,102
Distributions to partners (917)           (917)
Minimum pension liability,net (8) (8)       (8)  
Unrealized gains on investment, net 66 66       66  
Ending balance (in shares) at Sep. 30, 2024     19,030,474        
Ending balance at Sep. 30, 2024 $ 467,103 420,884 $ 1,903 68,313 350,588 80 46,219
Beginning balance (in shares) at Dec. 31, 2024 19,046,894   19,046,894        
Beginning balance at Dec. 31, 2024 $ 469,113 423,103 $ 1,905 68,876 352,267 55 46,010
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock option grant compensation 116 116   116      
Restricted stock compensation 972 972   972      
Shares granted to Directors (in shares)     21,900        
Shares granted to Directors 600 600 $ 2 598      
Restricted stock award (shares)     40,440        
Restricted stock award 0 0 $ 4 (4)      
Net income (loss) 2,823 2,950     2,950   (127)
Contributions from partner 1,208           1,208
Distributions to partners (12,613)           (12,613)
Minimum pension liability,net (23) (23)       (23)  
Unrealized gains on investment, net $ 0            
Ending balance (in shares) at Sep. 30, 2025 19,109,234   19,109,234        
Ending balance at Sep. 30, 2025 $ 462,196 427,718 $ 1,911 70,558 355,217 32 34,478
Beginning balance (in shares) at Jun. 30, 2025     19,109,234        
Beginning balance at Jun. 30, 2025 461,414 426,702 $ 1,911 70,196 354,555 40 34,712
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock option grant compensation 39 39   39      
Restricted stock compensation 323 323   323      
Net income (loss) 565 662     662   (97)
Contributions from partner 920           920
Distributions to partners (1,057)           (1,057)
Minimum pension liability,net (8) (8)       (8)  
Unrealized gains on investment, net $ 0            
Ending balance (in shares) at Sep. 30, 2025 19,109,234   19,109,234        
Ending balance at Sep. 30, 2025 $ 462,196 $ 427,718 $ 1,911 $ 70,558 $ 355,217 $ 32 $ 34,478